Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	13	4	4	19	23	36
Market Cap Growth	189.17%	2.56%	-79.50%	-16.24%	-37.40%	80.33%
Enterprise Value	-18	2	-2	11	22	33
PE Ratio	-	-0.31	-0.29	-1.39	-3.32	-5.13
PS Ratio	0.84	-	-	-	1891.53	13.57
PB Ratio	0.38	0.66	0.34	1.31	2.34	5.50
P/FCF Ratio	1.87	-0.42	-0.38	-1.78	-3.11	-4.47
P/OCF Ratio	1.87	-0.42	-0.38	-1.79	-3.12	-4.47
EV/Sales Ratio	-0.79	-	-	-	1837.10	12.17
EV/EBITDA Ratio	-4.30	-0.13	0.15	-0.83	-3.33	-4.82
EV/EBIT Ratio	-4.35	-0.13	0.15	-0.82	-3.24	-4.67
EV/FCF Ratio	-1.77	-0.17	0.19	-1.06	-3.02	-4.01
Debt / Equity Ratio	0.00	0.02	0.01	0.01	0.06	0.01
Debt / EBITDA Ratio	0.03	-0.01	-0.01	-0.02	-0.09	-0.01
Debt / FCF Ratio	0.01	-0.01	-0.01	-0.02	-0.08	-0.01
Quick Ratio	19.76	1.50	1.84	4.91	0.67	2.70
Current Ratio	21.02	2.90	2.35	5.59	0.87	3.06
Asset Turnover	0.70	0	0	0	0.00	0.25
Interest Coverage	261.35	-1115.02	-1591.82	-2037.14	-1635.34	-21541.46
Return on Equity (ROE)	14.50%	-137.30%	-129.50%	-100.00%	-83.70%	-93.50%
Return on Assets (ROA)	9.90%	-79.00%	-78.20%	-65.30%	-57.50%	-67.10%
Return on Capital (ROIC)	11.97%	-170.42%	-101.85%	-99.48%	-79.70%	-106.00%
Earnings Yield	17.03%	-324.75%	-346.82%	-72.07%	-30.08%	-19.48%
FCF Yield	53.39%	-237.92%	-266.09%	-56.21%	-32.17%	-22.38%
Buyback Yield / Dilution	-1779.59%	-561.21%	-203.73%	-110.04%	-44.34%	-34.47%
Total Shareholder Return	-1779.59%	-561.21%	-203.73%	-110.04%	-44.34%	-34.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).